Cosmo First
Cosmo First Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
3 of 3 strong
Not discussed on this call: fundraise, order book.
The short version
Overall business revenue expected to grow by 20% in the current year (FY27). Overall company revenue expected to grow by at least 20% in the current year (FY27). - New businesses projected to grow at a rapid pace of around 60% this year. - Specialty chemical business expected to grow ~50% with 25% EBITDA margins. - Plastech business turned profitable in Q1 FY27; targeting double-digit profitability by year-end and aiming for 15%-20%+ ROCE as it scales to Rs.
From Cosmo First's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Overall business revenue expected to grow by 20% in the current year (FY27).
- New businesses projected to grow at 60% in the current year.
- Specialty film sales aimed to increase to 35%-40% gross margins with scaling revenue, though this will take time.
- Cosmo Consumer business expected to grow rapidly, with over 3x growth projected this year in the domestic market.
- Zigly is scaling with a current run rate of ~Rs. 100 crores annualized and targets breakeven at Rs. 250 crores revenue in next couple of years.
- Plastech business projected to grow from Rs. 100 crores last year to Rs. 150-160 crores this year and ~Rs. 200+ crores next year, with improving margins and ROCE.
- US market expected to grow 25%-30% this year post duty rationalization, supporting export volume growth.
- 15% unused capacity in films and specialty products expected to be utilized in coming quarters, supporting volume growth.
Profitability & Margins
See what Cosmo First said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Minimal Capex planned over the next two years to contain significant capital expenditure.
- Recent investments have created substantial headroom to scale specialty films sales to close to 90% without major new Capex.
- On the Plastech side, capacity to be expanded by 50% with minimal Capex, enabling revenue growth from Rs. 100 crores to Rs. 200-250 crores by next year.
- Incremental Capex is directed primarily at specialty assets, including development and launch of new specialty films and products.
- Existing specialty business has sufficient capacity; new capacity added recently supports growth targets.
- No major capacity constraints for specialty films; focus is on scaling existing value-added assets.
- The company aims to reduce corporate net debt substantially in the next 2 years while improving ROCE and EBITDA, indicating capital discipline.
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Cosmo First said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Cosmo First — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.0K Cr, net profit ₹37 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Cosmo First Ltd's management said in earlier quarters
Others in Industrial Products this season
- Rathi Steel & Power Ltd (Q1 FY27)
PAT growth seen with recent quarters growing by ~85% YoY, indicating strong earnings momentum. Key concall takeaways from Rathi Steel & Power Ltd's Q1 FY27…
- SKP Bearing Industries Ltd (Q1 FY27)
SKP is steadily increasing capacity from about 80-100 tons earlier to around 1,800 tons now, operating at ~80% utilization (Page 20). Key concall takeaways…
- Mitsu Chem Plast Ltd (Q1 FY27)
Q1 FY27 showed strong profitability with EBITDA margin improving to 16.29% and net profit margin to 9.18%. Key concall takeaways from Mitsu Chem Plast Ltd's Q1…
- Simplex Castings Ltd (Q1 FY27)
Current capacity expansion planned for 300-350 crores revenue, further growth through organic or inorganic expansion. Key concall takeaways from Simplex…
Frequently Asked Questions
What were Cosmo First Q1 FY27 results?
Overall business revenue expected to grow by 20% in the current year (FY27). Overall company revenue expected to grow by at least 20% in the current year (FY27). - New businesses projected to grow at a rapid pace of around 60% this year. - Specialty chemical business expected to grow ~50% with 25% EBITDA margins. - Plastech business turned profitable in Q1 FY27; targeting double-digit profitability by year-end and aiming for 15%-20%+ ROCE as it scales to Rs.
What is Cosmo First share price analysis?
Cosmo First currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 14.1 with a market cap of ₹2,423 Cr. Investors should review the full earnings analysis for detailed insights.
Is Cosmo First planning capital expenditure?
Minimal Capex planned over the next two years to contain significant capital expenditure. - Recent investments have created substantial headroom to scale specialty films sales to close to 90% without major new Capex. - On the Plastech side, capacity to be expanded by 50% with minimal Capex, enabling revenue growth from Rs.
Keep Cosmo First on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
